Odence-Ford Marion
Insider CIK 1845002 · OPRX General Counsel and CCO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | F Tax w/h | 2026-08-21 | 2026-08-24 | 1,529 | $7.71 | $11.8K | 90,407 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2026-08-21 | 2026-08-24 | 1,529 | $7.71 | $11.8K | 90,407 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2026-08-20 | 2026-08-24 | 57,600 | — | $0 | 148,007 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2026-08-20 | 2026-08-24 | 57,600 | — | $0 | 148,007 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2026-02-11 | 2026-02-13 | 4,000 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2026-02-11 | 2026-02-13 | 1,386 | $9.23 | $12.8K | 91,936 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2026-02-11 | 2026-02-13 | 4,000 | — | $0 | 93,322 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-12-23 | 2025-12-23 | 4,051 | $12.74 | $51.6K | 89,322 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-12-19 | 2025-12-22 | 3,928 | — | $0 | 3,928 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-12-19 | 2025-12-22 | 1,153 | $13.51 | $15.6K | 93,373 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-12-19 | 2025-12-22 | 3,928 | — | $0 | 94,526 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-10-03 | 2025-10-07 | 6,649 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-10-03 | 2025-10-07 | 6,649 | — | $0 | 92,550 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-10-03 | 2025-10-07 | 1,952 | $18.75 | $36.6K | 90,598 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2025-08-21 | 2025-08-25 | 35,156 | — | $0 | 35,156 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2025-08-21 | 2025-08-25 | 15,625 | — | $0 | 85,901 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-03-01 | 2025-03-04 | 771 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-03-01 | 2025-03-04 | 268 | $5.18 | $1.4K | 70,276 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-03-01 | 2025-03-04 | 771 | — | $0 | 70,544 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-02-15 | 2025-02-20 | 1,479 | $6.64 | $9.8K | 69,773 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2025-02-11 | 2025-02-13 | 4,000 | — | $0 | 12,000 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2025-02-11 | 2025-02-13 | 4,000 | — | $0 | 72,638 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2025-02-11 | 2025-02-13 | 1,386 | $5.60 | $7.8K | 71,252 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2024-12-23 | 2024-12-27 | 77,742 | — | $0 | 77,742 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-12-23 | 2024-12-27 | 41,408 | — | $0 | 68,638 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-12-20 | 2024-12-20 | 1,153 | $4.75 | $5.5K | 27,230 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-12-19 | 2024-12-20 | 3,927 | — | $0 | 7,856 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-12-19 | 2024-12-20 | 3,927 | — | $0 | 28,383 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-11-08 | 2024-11-12 | 1,785 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-11-08 | 2024-11-12 | 1,785 | — | $0 | 24,980 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-11-08 | 2024-11-12 | 524 | $6.27 | $3.3K | 24,456 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-10-03 | 2024-10-07 | 6,649 | — | $0 | 6,649 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-10-03 | 2024-10-07 | 6,649 | — | $0 | 25,147 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-10-03 | 2024-10-07 | 1,952 | $7.83 | $15.3K | 23,195 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-03-01 | 2024-03-06 | 771 | — | $0 | 771 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-03-01 | 2024-03-06 | 268 | $15.95 | $4.3K | 14,231 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-03-01 | 2024-03-06 | 771 | — | $0 | 14,499 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-02-15 | 2024-04-24 | 4,267 | — | $0 | 18,498 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-02-11 | 2024-02-13 | 4,000 | — | $0 | 16,000 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-02-11 | 2024-02-13 | 4,000 | — | $0 | 15,114 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2024-02-11 | 2024-02-13 | 1,386 | $15.39 | $21.3K | 13,728 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2024-01-09 | 2024-01-11 | 4,000 | $15.19 | $60.8K | 11,114 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2023-12-19 | 2024-02-21 | 11,783 | — | $0 | 11,783 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2023-12-19 | 2024-02-21 | 11,783 | — | $0 | 11,783 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-11-08 | 2023-11-13 | 1,785 | — | $0 | 1,785 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-11-08 | 2023-11-13 | 1,785 | — | $0 | 15,638 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-11-08 | 2023-11-13 | 524 | $9.21 | $4.8K | 15,114 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-10-03 | 2023-10-06 | 6,649 | — | $0 | 13,298 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-10-03 | 2023-10-06 | 1,952 | $7.06 | $13.8K | 13,853 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-10-03 | 2023-10-06 | 6,649 | — | $0 | 15,805 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-03-01 | 2023-03-03 | 771 | — | $0 | 1,542 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-03-01 | 2023-03-03 | 268 | $18.11 | $4.9K | 9,156 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-03-01 | 2023-03-03 | 771 | — | $0 | 9,424 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-02-11 | 2023-02-14 | 4,000 | — | $0 | 12,000 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2023-02-11 | 2023-02-14 | 1,422 | $17.34 | $24.7K | 8,653 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-02-11 | 2023-02-14 | 4,000 | — | $0 | 10,075 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-11-08 | 2022-11-10 | 1,785 | — | $0 | 3,570 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-11-08 | 2022-11-10 | 1,785 | — | $0 | 6,785 | SEC↗ |
| OPRX OptimizeRx Corp | F Tax w/h | 2022-11-08 | 2022-11-10 | 710 | $14.52 | $10.3K | 6,075 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-10-03 | 2022-10-05 | 39,055 | — | $0 | 39,055 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-10-03 | 2022-10-05 | 19,947 | — | $0 | 19,947 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2022-08-26 | 2022-08-30 | 1,000 | $15.75 | $15.8K | 5,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 2,313 | — | $0 | 2,313 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 4,690 | — | $0 | 4,690 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-02-11 | 2022-02-15 | 4,000 | — | $0 | 16,000 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-02-11 | 2022-02-15 | 4,000 | — | $0 | 4,000 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-11-08 | 2021-11-10 | 10,958 | — | $0 | 10,958 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-11-08 | 2021-11-10 | 5,355 | — | $0 | 25,335 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-02-11 | 2021-02-12 | 20,000 | — | $0 | 20,000 | SEC↗ |